Research paperIdentification and characterisation of a salt form of Danirixin with reduced pharmacokinetic variability in patient populations
-
Add time:08/22/2019 Source:sciencedirect.com
The natural variability of gastric pH or gastric acid reducing medications can result in lower and more variable clinical pharmacokinetics for basic compounds in patient populations. Progressing alternative salt forms with improved solubility and dissolution properties can minimise this concern. This manuscript outlines a nonclinical approach comprising multiple biopharmaceutical, in vitro and physiologically based pharmacokinetic model (PBPK) modelling studies to enable selection of an alternative salt form for danirixin (DNX, GSK1325756), a pharmaceutical agent being developed for chronic obstructive pulmonary disease (COPD). The hydrobromide salt of DNX was identified as having superior biopharmaceutical properties compared to the free base (FB) form in clinical development and the impact of switching to the hydrobromide salt (HBr) was predicted by integrating the nonclinical data in a PBPK model (using GastroPlus™) to enable simulation of clinical drug exposure with FB and HBr salts in the absence and presence of a gastric acid reducing comedication (omeprazole, a proton pump inhibitor (PPI)). Subsequent investigation of DNX pharmacokinetics in a Phase 1 clinical study comparing FB with HBr salt forms confirmed that DNX HBr had reduced the variability of drug exposure and that exposure was not affected by PPI co-administration with DNX HBr. This case study therefore adds to the surprisingly few examples of a more soluble salt of a weak base translating to an improvement in human pharmacokinetics and illustrates a clear clinical benefit of salt selection during drug development.
We also recommend Trading Suppliers and Manufacturers of DL-MANDELIC ACID SODIUM SALT (cas 114-21-6). Pls Click Website Link as below: cas 114-21-6 suppliers
Prev:Molecular spectroscopySpectral and electrochemical studies of d-tartaric and dl-mandelic acids with different chromium ions
Next:Polyethylenimine-capped silver nanoclusters as fluorescent sensors for the rapid detection of ellagic acid in cosmetics) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Analysis of the sodium lactate concentration process by electrodialysis08/28/2019
- 9.09 High-Throughput Screening to Enable Salt and Polymorph Screening, Chemical Purification, and Chiral Resolution08/27/2019
- Simple dilute-and-shoot method for urinary vanillylmandelic acid and homovanillic acid by liquid chromatography tandem mass spectrometry08/26/2019
- On the synthesis and identification of the epinephrin metabolite 4-hydroxy-3-methoxy-dl-mandelic acid08/25/2019
- Enantiomeric and racemic effect of tartaric acid on polysulfone membrane during crystal violet dye removal by MEUF process08/24/2019
- Polyethylenimine-capped silver nanoclusters as fluorescent sensors for the rapid detection of ellagic acid in cosmetics08/23/2019
- Molecular spectroscopySpectral and electrochemical studies of d-tartaric and dl-mandelic acids with different chromium ions08/21/2019
-
Health and Chemical more >


